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Why?ABSTRACT
Background. Although the overall rate of antibiotic prescribing has beenFawziah Marra, PharmD; Diana George, MSc;
Mei Chong, MSc; Susan Sutherland, DDS,
MSc; David M. Patrick, MD, MHScdeclining in British Columbia, Canada, the authors conducted a study to
explain the increased rate of prescribing by dentists.
Methods. The authors obtained anonymized, line-listed data on outpa-
tient prescriptions from 1996 to 2013 from a centralized, population-based
prescription database, including a variable coding prescriber licensing
body. Analyses used Anatomical Therapeutic Classiﬁcation standard codes
and deﬁned daily dose (DDD) values. The authors normalized prescribing
rates to the population and expressed the rates in DDDs per 1,000 in-
habitants per day (DID). The Canadian Dental Association released a
webinar that invited correspondence from dentists about the drivers of the
trend.
Results. From 1996 to 2013, overall antibiotic use declined from 18.24T he discovery and use of antibioticshas averted many deaths, trans-formed medical practice,and provided new tools to public
health for communicable disease control.1
Today, these gains are at risk of being
reversed, owing to natural selection for
resistant bacteria. With few immediate
prospects of new antibiotic classes, in-
vestigators should focus attention onDID to 15.91 DID, and physician prescribing declined 18.2%, from 17.25
DID to 14.11 DID. However, dental prescribing increased 62.2%, from 0.98
DID to 1.59DID, and its proportionate contribution increased from6.7% to
11.3% of antibiotic prescriptions. The rate of prescribing increased themost
for dental patients 60 years or older. Communication from dentists in
Canada and the United States identiﬁed the following explanatory themes:
unnecessary prescriptions for periapical abscess and irreversible pulpitis;
increased prescribing associated with dental implants and their complica-
tions; slow adoption of guidelines calling for less perioperative antibiotic
coverage for patients with valvular heart disease and prosthetic joints;preserving the value of
antibiotics currently in
use through active
surveillance and anti-
microbial steward-
ship.2,3 The results of
ecological studies
have shown that the
overuse of antibiotics
at the populationemphasis on cosmetic practices reducing the surgical skill set of average
dentists; underinsurance practices driving antibiotics to be a substitute for
surgery; the aging population; and more dental registrants per capita.
Conclusions. Emerging themes for dental prescribing should be explored
further in future studies; however, themes already identiﬁed may guide
priorities in antibiotic stewardship for continuing dental education
sessions.level leads to resistance.4,5 Antimicrobial
stewardship efforts in the hospital and
community sectors are informed by sur-
veillance of antibiotic use over time.6 Since
2001, the Canadian province of British
Columbia (BC) has emulated European
jurisdictions and established surveillancepanying online continuing
ble at: http://jada.ada.org/
an Dental Association. This is
der the CC BY-NC-ND license
.org/licenses/by-nc-nd/4.0/).
Practical Implications. Antibiotic prescribing should be reviewed to
make sure that we are compliant with guidelines. Most practitioners will
ﬁnd opportunities to prescribe less often and for shorter durations.
Key Words. Antibiotics; antimicrobial stewardship; prescribing;
dentists.
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TABLE 1
Community antibiotic prescribing, according to profession in British Columbia,
Canada.
PROFESSION* PERCENTAGE OF
RETAIL ORAL
ANTIBIOTIC
PRESCRIPTIONS
IN 2013
RATE OF UTILIZATION AT FIRST
YEAR OF PRESCRIBING IN DATA
RATE OF
UTILIZATION
(DID) IN 2013
PERCENTAGE CHANGE IN
UTILIZATION RATE (FROM
FIRST YEAR OF
PRESCRIBING TO 2013)
MEAN DDD‡
PER
PRESCRIPTION
2013Year DID
†
Physicians
and Surgeons
87.52 1996 17.25 14.11 18.20 10.63
Dentists 11.27 1996 0.98 1.59 62.24 9.33
Pharmacists 0.38 1996 5.20 x 103 0.05 900.00 8.57
Podiatrists 0.10 1996 9.05 x 103 0.01 55.56 8.78
Midwives 0.04 1998 9.42 x 105 4.45 x 103 4.84 x 103 8.41
Nurses 0.59 2005 1.96 x 104 0.09 4.29 x 104 9.67
Naturopathic
Physicians
0.10 2010 0.01 0.06 500.00 35.20
* Data for optometrists are not presented in this table and accounted for 0.001% of prescriptions in 2013.
† DID: Deﬁned daily doses per 1,000 inhabitants per day.
‡ DDD: Deﬁned daily dose.
ABBREVIATION KEY. AAOS: American Academy of Or-
thopaedic Surgeons. ADA: American Dental Association. BC:
British Columbia. DDD: Deﬁned daily dose. DID: Deﬁned
daily doses per 1,000 inhabitants per day.
ORIGINAL CONTRIBUTIONSfor antimicrobial use. Data inform educational
messaging on antimicrobial use for physicians and the
public. Investigators have noted a 12.7% reduction in
the overall rate of prescribing antibiotics between 1996
and 2013.7
Antibiotic stewardship efforts within the health care
community traditionally have focused on physicians as
prescribers, yet other health care professionals in BC
also may prescribe, a practice that has yet to be assessed
in Canada.8,9 These prescribers include dentists, nurse
practitioners, and naturopathic physicians; however,
because the latter 2 types of clinicians prescribe fewer
than 1% of all the prescriptions, we evaluated the pre-
scribing practices of dentists, the second most active
prescribing profession.
METHODS
The University of British Columbia Institutional Review
Board approved the protocol (certiﬁcate H09-00650). All
outpatient prescriptions in BC are entered in the BC
PharmaNet database.10 We obtained anonymized, line-
listed data, which included a variable coding for the
licensing body of the prescriber, for all oral antibiotic
prescriptions from 1996 to 2013. We conducted analyses
in SAS (SAS Institute) and Excel (Microsoft), using the
World Health Organization’s Anatomical Therapeutic
Classiﬁcation standard codes and the deﬁned daily dose
(DDD), a unit of drug consumption measurement that is
independent of different drug preparations. The DDD is
the assumed average maintenance dose per day for a
drug used for its main indication in adults and does
not reﬂect the recommended or prescribed daily dose.
We normalized the rates of prescribing to the BC pop-
ulation11 and expressed in DDDs per 1,000 inhabitants
per day (DID).We conducted analyses for overall antibiotic use by
profession and also for rates of prescribing of drug
classes and individual drugs by dentists. Mean DDD per
prescription was calculated as a proxy for the length of
time that the antibiotics were prescribed. Because BC
PharmaNet contains all outpatient prescriptions for the
population of BC, statistical inference was not required
to assess generalizability from a sample. We assessed the
signiﬁcance of trends by using the Spearman rank
correlation.
To inform an understanding of possible reasons for
prescribing, we broadcast a webinar from the Canadian
Dental Association that described trends in dental use.
One author (D.M.P.) logged and organized the return
e-mail communications according to theme.
RESULTS
Antimicrobial prescriptions. In 2013, BC practitioners
wrote 2.6 million antibiotic prescriptions, of which
physicians contributed 87.5%, dentists 11.3%, nurse
practitioners 0.60%, pharmacists 0.40%, podiatrists
0.10%, naturopathic physicians 0.10%, and midwives
0.04% (Table 1).
Figure 1 illustrates the temporal trends in prescribing
by profession. From 1996 to 2013, overall antibiotic use in
BC declined from 18.24 DID to 15.91 DID. Prescriptions
by physicians declined signiﬁcantly, by 18.2%, from 17.25
to 14.11 DID (P < .001). For dentists, there was a sub-
stantial and statistically signiﬁcant increase of 62.2%JADA 147(5) http://jada.ada.org May 2016 321
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Figure 1. Rate of antibiotic use by prescribing profession, British Columbia (BC), 1996-2013. All trends over
time presented in this ﬁgure are statistically signiﬁcant according to the nonparametric Spearman rank correla-
tion (P < .001). DDD: Deﬁned daily dose.
ORIGINAL CONTRIBUTIONSin the rate of prescribing, from 0.98 DID to 1.59 DID
(P < .0001). The percentage of antibiotic use provided
by dentists increased from 5.4% to 10.0% of DID, and
the percentage of prescriptions provided by dentists
increased from 6.7% to 11.3%.
Figure 2 and Table 2 depict trends in dental antibiotic
prescribing by drug class and by leading agents. The
increase in overall antibiotic prescribing is driven largely
by the use of penicillin beta-lactams, which increased
71.6% between 1996 and 2013 (Figure 2). Also, there were
increases in the use of the class of macrolides and
lincosamides and of the quinolone class of antibiotics,
with concurrent decline in the use of trimethoprim-
sulfamethoxazole and cephalosporins.
In 2013, amoxicillin and clindamycin were the most
commonly used individual agents in dentistry, at 1.26
DID and 0.12 DID, respectively (Table 2). Although
the use of these agents has increased markedly since 1996;
in 2013, the use of simple penicillin V has declined
substantially and accounts for only 0.09 DID, or 5.6% of
use. The use of amoxicillin and enzyme inhibitor com-
binations has increased more than 2,000% between 1996
and 2013.
A breakdown of dental antibiotic use by patient age
group (Figure 3) reveals that BC residents aged 40 to 59
years had the highest rate of consumption from 1996 to
2009 (1.39-1.90 DID). However, BC residents 60 years or
older have had a more rapid increase in dental antibiotic
use, and their use surpassed the use of 40- to 59-year-olds322 JADA 147(5) http://jada.ada.org May 2016in 2010. By 2013, BC
residents 60 years or
older had the highest
rate among all age groups
(2.17 DID). We also
observed a steady in-
crease in the 15- to 19-
year-old age group, from
0.78 DID in 1996 to 1.78
DID in 2013. In 2013, rates
of use were similar for
men and women, at 1.59
and 1.60 DID, respec-
tively (data not shown).
We assessed the mean
number of DDD per
prescription in 2013 for
dentists as a proxy for
duration of therapy.
Dentists prescribed in
the same range (9.33
DDD per prescription)
as most other practi-
tioners. The outlying
profession for this metric
was naturopathic physi-
cians, who prescribed amean of 35.20 DDD per prescription; we have discussed
this observation with members of that profession. The
mean DDD per prescription for all other professions fell
within a range of 8.41 to 10.63 DDD (Table 1).
Themes identiﬁed in correspondence after the
webinar. As of December 3, 2015, 1,798 practitioners (2%
from the United States and the remainder from Canada)
had accessed the webinar. Sixteen dentists (25% from the
United States and 75% from Canada) contributed 30
communications to one of the authors (D.M.P.) after the
event. Eleven explanatory themes emerged, most of
which were supported by the literature (Table 3). Themes
included unnecessary prescription for periapical ab-
scesses and irreversible pulpitis; increased use with dental
implants and associated complications; slow adoption of
new guidelines calling for less perioperative antibiotic
coverage for patients with valvular heart disease and
prosthetic joints; emphasis on cosmetic practice poten-
tially reducing the surgical skill set of the average dentist;
underinsurance driving antibiotics as a substitute for
surgery; an aging population; and more dental registrants
per capita in BC.
DISCUSSION
Our study is the ﬁrst in Canada to describe antibiotic
prescribing rates by dentists. Although physicians ac-
count for providing the most antibiotic prescriptions, our
study results showed a substantial increase in the pro-
portionate and absolute prescribing rates by dentists in
TABLE 2
Utilization rate, according to antibiotic drug
and percentage change, 1996 to 2013,
dentists, British Columbia.
DRUG* RATE OF
UTILIZATION
(DID†)
IN 1996
RATE OF
UTILIZATION
(DID)
IN 2013
PERCENTAGE
CHANGE
FROM 1996
TO 2013
Amoxicillin 0.52 1.26 143
Clindamycin 0.014 0.12 789
Phenoxymethylpenicillin
(Penicillin V)
0.27 0.09 67
Amoxicillin and Enzyme
Inhibitor
1.49 x 103 0.04 2,240
Doxycycline 0.023 0.024 4.3
* Only drugs that accounted for greater than 1% of utilization by dentists in 2013 are
presented.
† DID: Deﬁned daily doses per 1,000 inhabitants per day.
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J01—Antibacterials for systemic use*
J01C—Beta-lactam antibacterials, penicillins*
J01E—Sulfonamides and trimethoprim*
J01M—Quinolone antibacterials*
J01A—Tetracyclines*
J01D—Other beta-lactam antibacterials
J01F—Macrolides, lincosamides and streptogramins*
J01X—Other antibacterials
Figure 2. Rate of antibiotic use by antibiotic drug class among prescriptions by dentists, British Columbia, 1996-2013. Anatomical Therapeutic
classiﬁcation standard codes for antibiotic drug classes are included. *: Trends over time are statistically signiﬁcant according to the nonparametric
Spearman rank correlation (P < .001). DDD: Deﬁned daily dose.
ORIGINAL CONTRIBUTIONSBC. Although dentists in BC contributed only
11.3% of the antibiotic prescriptions in 2013,
the absolute increase in dental prescribing
was sufﬁcient to substantially blunt the ex-
pected decline in antibiotic use at a popula-
tion level associated with observed changes in
physician practice.
Our study results also showed that the
prescribing of the narrow spectrum agent,
penicillin V, has decreased signiﬁcantly,
whereas the use of amoxicillin and combi-
nations of amoxicillin and enzyme inhibitors
has increased. This is of concern because
penicillin V continues to be recommended as
a ﬁrst-line agent for many dental indications
and it retains suitable coverage across much
of the oral ﬂora. Dentists in the United States
contributed a similar proportion (10%) of all
antibiotic prescriptions,12 whereas the dental
contribution was lower (7-8%) in Europe.13-18Investigators in other countries also have reported the
dominant use of amoxicillin.19,20
The increase in antibiotic prescribing by dentists that
we observed in our study is of concern as it is occurring
at a time when the use of recommendations and guide-
lines should be producing a decrease.21,22 One of thethemes we heard from participants in the webinar
centered on overprescribing for periapical abscesses and
irreversible pulpitis. An acute periapical abscess is a
localized infection that causes an intense inﬂammatory
response, resulting in severe and throbbing pain. In 2005,
dentists debated whether reducing the inﬂammatoryJADA 147(5) http://jada.ada.org May 2016 323
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Figure 3. Rate of antibiotic use by age group among prescriptions by dentists, British Columbia, 1996-2013.
*: Includes prescriptions for patients 14 years or younger, which account for 3% to 6% of all dental prescriptions
per year. All trends over time presented in this ﬁgure are statistically signiﬁcant according to the nonparametric
Spearman rank correlation (P < .001). DDD: Deﬁned daily dose.
ORIGINAL CONTRIBUTIONSresponse by using nonsteroidal anti-inﬂammatory drugs
or eliminating the bacteria by using antibiotics was the
most appropriate treatment response.23 However, in 2013,
the investigators of a systematic review and meta-
analysis concluded that periapical abscesses should be
drained through a pulpectomy or incision and drainage
and that the use of antibiotics was of no additional
beneﬁt in terms of the outcomes of pain or infection.24
Another identiﬁed reason for overprescribing is the
slow or incomplete adoption of new guidelines calling for
a descreased use of perioperative antibiotics in patients
with valvular heart disease and prosthetic joints. Rec-
ommendations for prophylaxis in patients with valvular
heart disease were revised in 2007 and 2008.25-27 Pro-
phylaxis against infective endocarditis is not recom-
mended for the American Heart Association–deﬁned
moderate-risk group of cardiac patients. Even for pa-
tients at high risk of experiencing complications (for
example, patients who have mechanical valves) prophy-
laxis is not recommended for a number of minor pro-
cedures, including routine anesthetic injection; dental
radiography; or placement, removal or adjustment of
prosthodontic and orthodontic devices. Given the revised
guidelines, we would expect a decrease in the use of
amoxicillin after 2008, but because we did not observe324 JADA 147(5) http://jada.ada.org May 2016such a decrease, we
conclude that there has
been poor translation of
guidelines into practice.28
Furthermore, although
prophylaxis is not rec-
ommended for patients
with nonvalvular
vascular devices (for
example, pacemakers,
deﬁbrillators, shunts,
grafts, and stents), anec-
dotal evidence suggests
that dentists often pre-
scribe prophylactic anti-
biotics for patients with
these devices.29
Guidelines and
advice for prophylaxis
before undergoing
invasive dental pro-
cedures for patients
with total joint replace-
ment began to emerge
in the 1970s.30 Attention
focused on the role of
dental procedure–
induced bacteremia in
late prosthetic joint in-
fections, and orthopedic
surgeons, infectiousdisease physicians, and dentists widely supported
recommendations for antibiotic coverage for all pa-
tients with total joint replacement.31 Although support
for prophylaxis appears to have diminished among
infectious disease specialists,32 Canadian orthopedic
surgeons and dentists surveyed in 2013 indicated that
they prescribed antibiotics prophylactically (77% and
71%, respectively) to patients before undergoing
invasive dental procedures,33 and that they had dif-
ferences in opinion regarding the duration of the
practice; orthopedic surgeons were signiﬁcantly more
likely to advocate lifelong coverage (63%), whereas
only 22% of dentists favoured that practice—most
dentists endorsed prophylaxis for the ﬁrst 2 years after
total joint replacement.
Since the 1970s, recommendations for coverage
for orthopedic patients have undergone numerous iter-
ations, resulting in confusion among practitioners and
patients.34,35 In 1997, the American Academy of Ortho-
paedic Surgeons (AAOS), the American Dental Associ-
ation (ADA) and the Infectious Diseases Society of
America published a consensus-based advisory state-
ment, which was revised in 2003.36 The statement
recommended prophylaxis for deﬁned “high-risk” con-
ditions and for all patients during the ﬁrst 2 years after
TABLE 3
Explanatory themes identiﬁed by 16 dentists for increasing rates of antibiotic
prescribing.
THEME (NO. OF RESPONDENTS) SPECIFIC COMMENTS
Treatment of Periapical Abscess (6) Deﬁnitive treatment should be surgical.
Treatment of Irreversible Pulpitis (4) Deﬁnitive treatment should be surgical.
Prophylaxis for Third-molar Surgery (1) Not available.
Increase in Prescription in Association With Dental
Implants and Bone Grafting (4)
Large growth in use of dental implants, especially by general practitioners, may be driving an
increase in prescribing for prophylaxis and treatment of complications.
Perioperative Prophylaxis for Patients With
Prosthetic Joints (5)
Practitioners slow to adopt new, more restrictive guidelines. Orthopedic surgeons also may
be ambivalent about new guidelines.
Perioperative Prophylaxis for Patients With
Valvular Heart Disease (6)
Practitioners slow to adopt new, more restrictive guidelines.
Shift to Cosmetic Practice (3) Dentists with cosmetic practices may be more likely to refer patients to other practitioners for
surgery and use antibiotics while the patient is waiting. May have less experience with repeat
endodontic procedures.
Insufﬁcient Awareness of Dentists’ Role in
Antibiotic Resistance (2)
Most public and media awareness campaigns focus on physician use. Comparably few
articles in the dental literature focus on Clostridium difﬁcile and other complications of
antibiotic use.
Impact of Underinsurance (2) Practitioners may be more likely to prescribe an antibiotic for underinsured patients than
commit more ofﬁce time to surgical management.
Aging Population (2) Older patients may be receiving more implant surgery.
More Dental Registrants per Capita (2) An increase in registrants should not increase a population’s requirement for antibiotics.
However, an increase in procedures may drive increase in prescription.
ORIGINAL CONTRIBUTIONStotal joint replacement. In 2012, the AAOS and ADA
published a systematic review and accompanying
guideline.37 Although the evidence reviewers found no
association between dental procedures and prosthetic
joint infections, and in fact, noted that daily activities
such as chewing, brushing, and ﬂossing induced many
more bacteremias than dental procedures, the guidelines
offered no clear recommendations for or against antibi-
otic prophylaxis.37 Citing existing evidence, as well as
addressing a concern about frequent, widespread anti-
biotic use, both the Canadian Dental Association and the
ADA have taken the position that prophylactic antibi-
otics are not recommended before undergoing dental
procedures to prevent prosthetic joint infections.38,39
Changing patterns in use according to patient age are
instructive. Increases in prescribing within well demar-
cated age strata mean that changes in use cannot be
blamed on an aging population alone. Rather, we must
look for changes in practice that affect the rate of pre-
scribing in each observed age stratum. Our analysis of
the input from our dental correspondents contributes to
the hypothesis that a more rapid increase in use has
occurred in patients 60 years or older due to the growth
in implant surgery and its distribution to more practices.
We also saw increasing use in patients aged 15 to 19 years,
which may be linked to third-molar extraction. Surgical
removal of mandibular third molars is one of the most
frequently performed procedures by both general den-
tists and oral surgeons; the use of postoperative antibi-
otics is common for this procedure.40 However, although
there is some evidence that antibiotics reduce thecomplication rate, there is equal evidence to the con-
trary.40,41 Some clinicians believe that pain and compli-
cations after extraction are related to inﬂammation
rather than to an actual infection that requires an
antibiotic.40,41
Coverage for medical care is funded publicly and is
essentially universal in BC and across Canada, but the
same is not true for dental services. Underinsurance is a
substantial problem, as it also may be in the United
States. A decision to surgically manage an underinsured
patient can result in considerable lost income for a
dentist; this situation creates an incentive toward
choosing the quick option of offering an antibiotic pre-
scription, for example, even when this choice does not
represent deﬁnitive treatment.
We also have seen a clear increase in the ratio of
dentists to the population in BC. On the surface, the
burden of maxillofacial infections requiring treatment
with antibiotics should not increase because of a higher
ratio of practitioners to patients. If, however, the
increased availability of practitioners drives the rate
of dental procedures, and procedures, in turn,
drive prescribing, then there may be a logical connection.
Going forward, a number of opportunities could be
leveraged to reverse the upward trend in dental pre-
scribing. First, it will be relatively simple to continue to
plot trends in use by professions as indicators for pro-
grams that could change use patterns. For example,
practitioners have indicated that there is a clear oppor-
tunity to reduce rates of perioperative antibiotic pro-
phylaxis. Second, successful approaches to stewardshipJADA 147(5) http://jada.ada.org May 2016 325
ORIGINAL CONTRIBUTIONSin medicine also can translate to dentistry. Dentists are
adept at offering symptomatic relief, which is a key
element of care when any practitioner is refraining from
prescribing antibiotics. Third, explaining to patients the
risks of antibiotic use is important. Risks include expe-
riencing hypersensitivity, Clostridium difﬁcile infection,42
and disruption of the normal healthy microbiota, but
also extend to a risk of affecting contacts and community
through selection for more resistant organisms.9,43
Practitioners also may ﬁnd it helpful to share informa-
tional links to community stewardship sites with their
patients.
Our study had some important limitations. Data came
from 1 province, British Columbia, Canada. Unlike
medical care, dental care is not publicly insured in
Canada, so trends in practice may be similar to those
occurring in the United States. Because dentists in
BC cannot bill the Medical Services Plan of British
Columbia, a process that requires the submission of
a diagnostic code, we could not directly infer the in-
dications for antibiotic prescription by linking data as
we can for physicians. However, as we found in the
described experiences of the 16 dentists who responded
to the webinar, dentists were quick to engage in e-mail
correspondence and the themes they identiﬁed were
well supported by the literature. Because our study was
not a large, formal survey, however, the themes we have
identiﬁed should be validated further by investigators of
future, larger studies.
CONCLUSIONS
We documented a rather alarming increased rate of the
prescription of antibiotics by dental practitioners. When
maximizing antibiotic stewardship efforts in populations,
it is important to consider the role of all prescribing
professions, with an initial focus on dentistry. n
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